Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness

por Thompson Coon, J S, Liu, Z, Hoyle, M, Rogers, G, Green, C, Moxham, T, Welch, K, Stein, K
Publicado 2009

Reply: SUN vs BEVþIFN in first-line mRCC therapy: no evidence for a statistically significant difference in progression-free survival

por Thompson Coon, J S, Liu, Z, Hoyle, M, Rogers, G, Green, C, Moxham, T, Welch, K, Stein, K
Publicado 2010

Surveillance of cirrhosis for hepatocellular carcinoma: a cost–utility analysis

por Thompson Coon, J, Rogers, G, Hewson, P, Wright, D, Anderson, R, Jackson, S, Ryder, S, Cramp, M, Stein, K
Publicado 2008

A realist evaluation of a collaborative model to support research co-production in long-term care settings in England: the ExCHANGE protocol

por Wilkinson, K., Day, J., Thompson-Coon, J., Goodwin, V., Liabo, K., Coxon, G., Cox, G., Marriott, C., Lang, I. A.
Publicado 2021